NCT02245503已完成不适用
Comorbidity and Comedication During Prescription of ALNA® (Tamsulosin) for Patients With BPH (Benign Prostatic Hyperplasia)
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 7,391
- 主要终点
- Collection of information on concomitant diseases
研究概览
简要总结
The objectives of this post marketing surveillance study were to document the comorbidity and comedication during prescription of ALNA® (Tamsulosin) for patients with BPH (Benign Prostatic Hyperplasia).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Indication for the treatment with ALNA according to its summary of product characteristics (SPC)
排除标准
- •Patients fulfilling one of the general or specific contraindications listed in the ALNA SPC, particularly patients with known hypersensitivities against tamsulosin hydrochloride or any other ingredient of the product, orthostatic dysregulation or severe liver insufficiency cannot be included in the study
研究组 & 干预措施
Benign prostatic hyperplasia
Patients with symptomatic BPH to whom ALNA was prescribed
干预措施: Tamsulosin (Drug)
结局指标
主要结局
Collection of information on concomitant diseases
时间窗: day 1
Collection of information on concomitant treatment
时间窗: day 1
次要结局
- Number of patients with adverse drug reactions(up to 6 months)
研究者
相似试验
已完成
不适用
Post Marketing Surveillance Study for ADYNOVATE in South KoreaHemophilia ANCT03824522Takeda341
已完成
不适用
Post-marketing Surveillance of Long-term Administration of Inovelon Tablets in Patients With Lennox-Gastaut SyndromeLennox-Gastaut SyndromeNCT02175173Eisai Co., Ltd.707
已完成
不适用
Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)HypertensionNCT02262611Boehringer Ingelheim266
已完成
不适用
Post-Marketing Surveillance Study of Eribulin on the Status and Factors for the Development of Peripheral Neuropathy in Japan.HER2-negative Breast CancerBreast CancerNCT02371174Eisai Co., Ltd.651
已完成
不适用
Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in JapanLung Diseases, InterstitialNCT04325217Boehringer Ingelheim586